Bridgeway Capital Management’s Innophos Holdings, Inc. IPHS Stock Holding History

Bridgeway Capital Management’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,000	Closed	-$800K	–	1410
2019 Q4	$800K	Hold	25,000	–	–	0.01%	799
2019 Q3	$812K	Buy	+25,000	New	+$720K	0.01%	784
2017 Q2	–	Sell	-45,050	Closed	-$2.43M	–	1497
2017 Q1	$2.43M	Buy	45,050 +34,800	+340%	+$1.79M	0.03%	500
2016 Q4	$536K	Buy	10,250 +250	+3%	+$12.1K	0.01%	1068
2016 Q3	$390K	Hold	10,000	–	–	0.01%	1174
2016 Q2	$422K	Hold	10,000	–	–	0.01%	1115
2016 Q1	$309K	Hold	10,000	–	–	0.01%	1207
2015 Q4	$290K	Buy	+10,000	New	+$352K	0.01%	1207

Other funds holding IPHS

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bridgeway Capital Management's IPHS Position: Q1 2020 in Review

Bridgeway Capital Management sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 25,000 shares — an estimated $800K sold.

Bridgeway Capital Management first reported a position in IPHS in Q4 2015 and held it in 8 quarters. The position peaked at $2.43M in Q1 2017. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

Bridgeway Capital Management reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Bridgeway Capital Management sold 25,000 Innophos Holdings, Inc. shares in Q1 2020, an estimated $800K.
Bridgeway Capital Management first reported a position in Innophos Holdings, Inc. in Q4 2015 and held it in 8 quarters.
Bridgeway Capital Management's Innophos Holdings, Inc. position peaked at $2.43M in Q1 2017.
2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.